321 related articles for article (PubMed ID: 18174266)
1. Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
Hamada Y; Kono TN; Moriguchi Y; Higuchi M; Fukagawa M
Nephrol Dial Transplant; 2008 Jun; 23(6):1886-91. PubMed ID: 18174266
[TBL] [Abstract][Full Text] [Related]
2. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
Fischer MA; Morris CA; Winkelmayer WC; Avorn J
Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
[TBL] [Abstract][Full Text] [Related]
3. Effect of erythropoietin on hepcidin, DMT1 with IRE, and hephaestin gene expression in duodenum of rats.
Kong WN; Chang YZ; Wang SM; Zhai XL; Shang JX; Li LX; Duan XL
J Gastroenterol; 2008; 43(2):136-43. PubMed ID: 18306987
[TBL] [Abstract][Full Text] [Related]
4. Vitamin A deficiency increases hepcidin expression and oxidative stress in rat.
Arruda SF; Siqueira EM; de Valência FF
Nutrition; 2009 Apr; 25(4):472-8. PubMed ID: 19217259
[TBL] [Abstract][Full Text] [Related]
5. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
[TBL] [Abstract][Full Text] [Related]
6. Heart and iron deficiency anaemia in rats with renal insufficiency: the role of hepcidin.
Toblli JE; Cao G; Rivas C; Kulaksiz H
Nephrology (Carlton); 2008 Oct; 13(7):636-45. PubMed ID: 18808386
[TBL] [Abstract][Full Text] [Related]
7. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
8. Decreased DMT1 and increased ferroportin 1 expression is the mechanisms of reduced iron retention in macrophages by erythropoietin in rats.
Kong WN; Zhao SE; Duan XL; Yang Z; Qian ZM; Chang YZ
J Cell Biochem; 2008 May; 104(2):629-41. PubMed ID: 18189270
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin for clinicians.
Young B; Zaritsky J
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1384-7. PubMed ID: 19556376
[TBL] [Abstract][Full Text] [Related]
10. Adaptive changes of duodenal iron transport proteins in celiac disease.
Barisani D; Parafioriti A; Bardella MT; Zoller H; Conte D; Armiraglio E; Trovato C; Koch RO; Weiss G
Physiol Genomics; 2004 May; 17(3):316-25. PubMed ID: 15054143
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
12. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia.
Lasocki S; Millot S; Andrieu V; Lettéron P; Pilard N; Muzeau F; Thibaudeau O; Montravers P; Beaumont C
Crit Care Med; 2008 Aug; 36(8):2388-94. PubMed ID: 18664788
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
[TBL] [Abstract][Full Text] [Related]
14. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin in anemia and inflammation in chronic kidney disease.
Malyszko J; Mysliwiec M
Kidney Blood Press Res; 2007; 30(1):15-30. PubMed ID: 17215586
[TBL] [Abstract][Full Text] [Related]
16. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
Katodritou E; Terpos E; Zervas K; Speletas M; Kapetanos D; Kartsios C; Verrou E; Banti A; Effraimidou S; Christakis J
Ann Hematol; 2007 May; 86(5):369-76. PubMed ID: 17375302
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin promotes hepatic regeneration after extended liver resection in rats.
Schmeding M; Boas-Knoop S; Lippert S; Ruehl M; Somasundaram R; Dagdelen T; Neuhaus P; Neumann UP
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1125-31. PubMed ID: 18086112
[TBL] [Abstract][Full Text] [Related]
18. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
[TBL] [Abstract][Full Text] [Related]
19. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney.
Kulaksiz H; Theilig F; Bachmann S; Gehrke SG; Rost D; Janetzko A; Cetin Y; Stremmel W
J Endocrinol; 2005 Feb; 184(2):361-70. PubMed ID: 15684344
[TBL] [Abstract][Full Text] [Related]
20. Intravenous iron attenuates postvaccination anti-HBsAg titres after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapy.
Liu JH; Liu YL; Lin HH; Yang YF; Kuo HL; Lin PW; Huang CC
Int J Clin Pract; 2009 Mar; 63(3):387-93. PubMed ID: 18410348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
